LCLaura Caberlotto

Laura Caberlotto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Laura Caberlotto has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Corrado Priami

    Department of Computer Science University of Pisa Pisa Italy

    2 shared publications
  • Mario Lauria

    Fondazione the Microsoft Research–University of Trento Centre for Computational and Systems Biology (COSBI), Rovereto, Italy

    2 shared publications
  • Thanh-Phuong Nguyen

    The Microsoft Research, University of Trento Centre for Computational Systems Biology (COSBI), Piazza Manifattura 1, 38068 Rovereto, Italy

    2 shared publications
  • Thanh-Phuong Nguyen

    The Microsoft Research, University of Trento Centre for Computational Systems Biology (COSBI), Piazza Manifattura 1, 38068 Rovereto, Italy

    2 shared publications
  • Amanda J. Kiliaan

    Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands

    1 shared publication
  • Angelica Mazzali

    Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy

    1 shared publication

Latest Publications

  • Open Access

    Nutrition for the ageing brain: Towards evidence for an optimal diet

    by David Vauzour, Maria Camprubi-Robles, Sophie Miquel-Kergoat, Cristina Andres-Lacueva, Diána Bánáti, Pascale Barberger-Gateau, Gene L. Bowman, Laura Caberlotto, Robert Clarke, Eef Hogervorst, et al.


  • Prioritizing drug targets for non-alcoholic fatty liver disease based on comorbidity network analysis

    by Thanh-Phuong Nguyen, Thomas Sauter, Laura Caberlotto, Frank Lammert, Jochen G Schneider

    Background and aims: Non alcoholic fatty liver disease (NAFLD) is highly associated with other components of the metabolic syndrome, in particular obesity and diabetes. However, systematic network medicine approach of the complex phenotypic dependencies and comorbidities has yet to be performed. Our aim now is to identify novel drug targets for NAFLD treatment by a systematic in silico network analysis. Methods: We constructed an interaction network of curated genes relevant to NAFLD and its comorbid diseases of interest. Network mining was applied to characterize the NAFLD comorbidity network, and identify the key genes based on centrality ranking. Large-scale shortest path analyses showed NAFLD connectivity to other comorbid diseases and allowed inferring the molecular mechanisms underlying comorbidities. Results: Overall, we identified 594 disease genes, most of which (38.7%) were related to glucose metabolism disorders (n=230). Lipid metabolism disorders were represented by 116 genes, and obesity by 114 genes; 19 genes were associated with metabolic syndrome, and 30 genes with non-alcoholic fatty liver disease (NAFLD). Network construction on the 594 disease genes resulted in a network of 2175 proteins and 4605 interactions from the human protein reference database. Among the most central genes in the network, two genes were directly related to NAFLD (TGBF1 and F2) and eight new candidate genes were inferred. We identified ten key genes that were related to at least two diseases and then consecutively regulated the comorbidities between the diseases. Of note, most of the ten genes were related to lipid and glucose metabolism, and two (INS, IRS1) were involved in aldosterone-regulated sodium absorption and diabetes. Furthermore, we found a large number of paths linking the NAFLD-related genes to glucose and lipid metabolism disorders and obesity (46 143, 22 000 and 21 516 paths, respectively), in particular genes related to adipocytokine and PPAR signaling and cytokine-cytokine receptor interaction. Conclusions: The comorbidity network analysis of NAFLD allowed the identification of genes that could represent the most promising molecular targets for prioritization of drug therapy in NAFLD.

  • Systems biology approaches to study the molecular effects of caloric restriction and polyphenols on aging processes

    by Sébastien Lacroix, Mario Lauria, Marie-Pier Scott-Boyer, Luca Marchetti, Corrado Priami, Laura Caberlotto

    Worldwide population is aging, and a large part of the growing burden associated with age-related conditions can be prevented or delayed by promoting healthy lifestyle and normalizing metabolic risk factors. However, a better understanding of the pleiotropic effects of available nutritional interventions and their influence on the multiple processes affected by aging is needed to select and implement the most promising actions. New methods of analysis are required to tackle the complexity of the interplay between nutritional interventions and aging, and to make sense of a growing amount of -omics data being produced for this purpose. In this paper, we review how various systems biology-inspired methods of analysis can be applied to the study of the molecular basis of nutritional interventions promoting healthy aging, notably caloric restriction and polyphenol supplementation. We specifically focus on the role that different versions of network analysis, molecular signature identification and multi-omics data integration are playing in elucidating the complex mechanisms underlying nutrition, and provide some examples on how to extend the application of these methods using available microarray data.


  • Open Access

    Novel drug target identification for the treatment of dementia using multi-relational association mining

    by Thanh-Phuong Nguyen, Corrado Priami, Laura Caberlotto

    Dementia is a neurodegenerative condition of the brain in which there is a progressive and permanent loss of cognitive and mental performance. Despite the fact that the number of people with dementia worldwide is steadily increasing and regardless of the advances in the molecular characterization of the disease, current medical treatments for dementia are purely symptomatic and hardly effective. We present a novel multi-relational association mining method that integrates the huge amount of scientific data accumulated in recent years to predict potential novel targets for innovative therapeutic treatment of dementia. Owing to the ability of processing large volumes of heterogeneous data, our method achieves a high performance and predicts numerous drug targets including several serine threonine kinase and a G-protein coupled receptor. The predicted drug targets are mainly functionally related to metabolism, cell surface receptor signaling pathways, immune response, apoptosis and long-term memory. Among the highly represented kinase family and among the G-protein coupled receptors, DLG4 (PSD-95) and the bradikynin receptor 2 are highlighted also for their proposed role in memory and cognition, as described in previous studies. These novel putative targets hold promises for the development of novel therapeutic approaches for the treatment of dementia.


  • Open Access

    Network Analysis of Neurodegenerative Disease Highlights a Role of Toll-Like Receptor Signaling

    by Thanh-Phuong Nguyen, Laura Caberlotto, Melissa J. Morine, Corrado Priami

    Despite significant advances in the study of the molecular mechanisms altered in the development and progression of neurodegenerative diseases (NDs), the etiology is still enigmatic and the distinctions between diseases are not always entirely clear. We present an efficient computational method based on protein-protein interaction network (PPI) to model the functional network of NDs. The aim of this work is fourfold: (i) reconstruction of a PPI network relating to the NDs, (ii) construction of an association network between diseases based on proximity in the disease PPI network, (iii) quantification of disease associations, and (iv) inference of potential molecular mechanism involved in the diseases. The functional links of diseases not only showed overlap with the traditional classification in clinical settings, but also offered new insight into connections between diseases with limited clinical overlap. To gain an expanded view of the molecular mechanisms involved in NDs, both direct and indirect connector proteins were investigated. The method uncovered molecular relationships that are in common apparently distinct diseases and provided important insight into the molecular networks implicated in disease pathogenesis. In particular, the current analysis highlighted the Toll-like receptor signaling pathway as a potential candidate pathway to be targeted by therapy in neurodegeneration.


  • Open Access

    A systems biology investigation of neurodegenerative dementia reveals a pivotal role of autophagy

    by Laura Caberlotto, Thanh-Phuong Nguyen

    Neurodegenerative dementia comprises chronic and progressive illnesses with major clinical features represented by progressive and permanent loss of cognitive and mental performance, including impairment of memory and brain functions. Many different forms of neurodegenerative dementia exist, but they are all characterized by death of specific subpopulation of neurons and accumulation of proteins in the brain. We incorporated data from OMIM and primary molecular targets of drugs in the different phases of the drug discovery process to try to reveal possible hidden mechanism in neurodegenerative dementia. In the present study, a systems biology approach was used to investigate the molecular connections among seemingly distinct complex diseases with the shared clinical symptoms of dementia that could suggest related disease mechanisms.


  • Open Access

    The Central Role of AMP-Kinase and Energy Homeostasis Impairment in Alzheimer’s Disease: A Multifactor Network Analysis

    by Laura Caberlotto, Mario Lauria, Thanh-Phuong Nguyen, Marco Scotti

    Alzheimer’s disease is the most common cause of dementia worldwide, affecting the elderly population. It is characterized by the hallmark pathology of amyloid-β deposition, neurofibrillary tangle formation, and extensive neuronal degeneration in the brain. Wealth of data related to Alzheimer’s disease has been generated to date, nevertheless, the molecular mechanism underlying the etiology and pathophysiology of the disease is still unknown. Here we described a method for the combined analysis of multiple types of genome-wide data aimed at revealing convergent evidence interest that would not be captured by a standard molecular approach. Lists of Alzheimer-related genes (seed genes) were obtained from different sets of data on gene expression, SNPs, and molecular targets of drugs. Network analysis was applied for identifying the regions of the human protein-protein interaction network showing a significant enrichment in seed genes, and ultimately, in genes associated to Alzheimer’s disease, due to the cumulative effect of different combinations of the starting data sets. The functional properties of these enriched modules were characterized, effectively considering the role of both Alzheimer-related seed genes and genes that closely interact with them. This approach allowed us to present evidence in favor of one of the competing theories about AD underlying processes, specifically evidence supporting a predominant role of metabolism-associated biological process terms, including autophagy, insulin and fatty acid metabolic processes in Alzheimer, with a focus on AMP-activated protein kinase. This central regulator of cellular energy homeostasis regulates a series of brain functions altered in Alzheimer’s disease and could link genetic perturbation with neuronal transmission and energy regulation, representing a potential candidate to be targeted by therapy.


  • Discovery and structure–activity relationship of a novel spirocarbamate series of NPY Y5 antagonists

    by Colin P. Leslie, Jonathan Bentley, Matteo Biagetti, Stefania Contini, Romano Di Fabio, Daniele Donati, Thorsten Genski, Sebastien Guery, Angelica Mazzali, Giancarlo Merlo, et al.